Economic evaluation of general childhood vaccination against Haemophilus influenzae type b in Sweden

Scandinavian Journal of Infectious Diseases

Volumn 30, Issue 1, 1998, Pages 5-10

  Garpenholt, Örjan ^a   Silfverdal, Sven Arne ^a   Levin, Lars Åke ^b  

^a ÖREBRO MEDICAL CENTRE HOSPITAL   (Sweden)

^b LINKÖPING UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

HAEMOPHILUS INFLUENZAE TYPE B VACCINE;

ARTICLE; COHORT ANALYSIS; COST EFFECTIVENESS ANALYSIS; DRUG COST; DRUG EFFICACY; HAEMOPHILUS INFLUENZAE TYPE B; HEALTH PROGRAM; HUMAN; INFANT; INFLUENZA; INFLUENZA VACCINATION; MAJOR CLINICAL STUDY; NEWBORN; PRESCHOOL CHILD; RETROSPECTIVE STUDY; SWEDEN; VACCINATION;

CHILD, PRESCHOOL; COST-BENEFIT ANALYSIS; HAEMOPHILUS INFECTIONS; HAEMOPHILUS INFLUENZAE TYPE B; HAEMOPHILUS VACCINES; HUMANS; INFANT; SWEDEN; VACCINATION;

EID: 0031809288     PISSN: 00365548     EISSN: None     Source Type: Journal    
DOI: 10.1080/003655498750002222     Document Type: Article

References (40)

1. Takala A, Eskola J, Peltola H, Mäkelä H. Epidemiology of invasive Hacmophilus influenzae type b disease among children in Finland before vaccination with Haemophilus influenzae type b conjugate vaccine. Pediatr Infect Dis J 1989; 8: 297-302.
2. Shapiro ED, Ward JI. The epidemiology of disease caused by Haemophilus influenzae type b. Epidemiol Rev 1991; 13: 113-42.
3. Makela H, Takala A, Peltola H, Eskola J. Epidemiology of invasive Haemophilus influenzae type b disease. J Infect Dis 1992; 165 (Suppl 1): 2-6.
4. Trollfors B, Claesson B, Strangert K. H. influenzae-meningitis in Sweden 1981-83. Arch Dis Child 1987; 62: 1220-3.
5. Trollfors B, Nylen O, Strangert K. Acute epiglottitis in children and adults in Sweden 1981-3. Arch Dis Child 1990; 65: 491-4.
6. Kristensen K, Kaaber K, Ronne T, Larsen SO, Henrichsen J. Epidemiology of Hacmophilus influenzae type b infections among children in Denmark in 1985 to 1986. Acta Pacdiatr Scand 1990; 79: 587-92.
7. Peltola H, Rod TO, Jonsdottir K, Böttiger M, Coolidge JA. Life-threatening Haemophilus influenzae infections in Scandinavia: a five-country analysis of the incidence and the main clinical and bacteriologic characteristics. Rev Infect Dis 1990; 12: 708-15.
8. Hugosson S, Silfverdal S-A, Garpenholt Ö, Esbjörner E, Lindqvist B, Vikerfors T. el al. Invasive Haemophilus influenzac disease: epidemiology and clinical spectrum before large-scale H. influenzae type b vaccination. Scand J Infect Dis 1995; 27: 63-7.
9. Berg S, Trollfors B, Claesson B, Alestig K, Gothefors L, Hugosson S, Lindquist P, Olcén P, Romanus V, Strangert K. Incidence and prognosis of meningitis due to Haemophilus influenzae, Streptococcus pneumoniae and Neisseria meningitides in Sweden. Scand J Infect Dis 1996; 28: 247-52.
10. Berg S, Trollfors B, Claesson B, Nylén O, Hugosson S, Prellner K, Carenfelt C. Incidence, aetiology, and prognosis of acute epiglottitis in children and adults in Sweden. Scand J Infect Dis 1996; 28: 261-4.
11. Salwén K, Vikerfors T, Olcén P. Increased incidence of child-hood bacterial meningitis. A 25-year study in a defined population in Sweden. Scand J Infect Dis 1987; 19: 1-11.
12. Peltola H, Kilpi T, Anttila M. Rapid disappearance of Haemophilus influenzae type b meningitis after routine childhood immunisation with conjugate vaccines. Lancet 1992; 340: 592-4.
13. Aasen S. Haemophilus influenzae type b (Hib) - The disease which disappeared. The National Institute of Public Health. Oslo. MSIS-rapport 1994; 12.
14. Gade K, Rønne T. HIB-vaccination 1993. The National Serum Institute. Copenhagen. EPI-NYTT 1994; 10.
15. Garpenholt Ö, Silfverdal S-A, Hugosson S, Fredlund H, Bodin L, Romanus V, Olcén P. The impact of general childhood vaccination against H. influenzae type b in Sweden. Scand J Infect Dis 1996; 28: 165-9.
16. Adams WG, Deaver KA. Cochi SL, Plikaytis BD, Zell ER, Broome CV, Wenger JV. Decline of childhood Haemophilus influenzae type b (Hib) disease in the Hib vaccine era. JAMA 1993; 269: 221-6.
17. Murphy TV, White KE, Pastor P, Gabriel L, Medley F, Granoff DM, Osterholm MT. Declining incidence of Haemophilus influenzae type b disease since introduction of vaccination. JAMA 1993; 269: 246-8.
18. Singleton R, Davidson N, Desmet I, Berner J, Wainwright R, Bulkow L, et al. Decline of Haemophilus influenzae type b disease in a region of high risk: impact of passive and active immunization. Pediatr Infect Dis J 1994; 13: 362-7.
19. van Alphen L, Spanjaard L, van der Ende A, Dankert J. Predicted disappearance of Haemophilus influenzae type b meningitis in Netherlands. Lancet 1994; 344: 195.
20. National Board of Health, General guidelines for childhood vaccination. SOFSS 1992: 20.
21. Claesson B, Trollfors B, Jodal U, Rosenhall U. Incidence and prognosis of Haemophilus influenzae meningitis in a Swedish region. Pediatr Infect Dis 1984; 3: 35-9.
22. Claesson B, Trollfors B, Ekström-Jodal B, Jeppsson P-H. Lagergård T, Nylén O, Ringnér P. Incidence and prognosis of acute epiglottitis in children in a Swedish region. Pediatr Infect Dis J 1984; 3: 534-8.
23. Clements D, Booy R, Dagan R, Gwendolyn G, Moxon R, Slack M, et al. Comparison of the epidemiology and cost of Haemophilus influenzae type b Disease in five western countries. Pediatr Infect Dis J 1993; 12: 363-7.
24. Butt W, Shann F, Walker C, Williams J, Duncan A, Phelan P. Acute epiglottitis: A different approach to management. Crit Care Med 1988; 16: 43-7.
25. Baraff L, Lee S, Schriger D. Outcomes of bacterial meningitis in children a metanalysis. Pediatr Infect Dis J 1993; 12: 389-94.
26. Statistics Bureau of Sweden. Statistics of Sweden [In Swedish] 1994 & 1995.
27. Eskola J. Use of conjugate vaccines to prevent meningitis caused by Haemophilus influenzae type b or Streptococcus pneumoniae. J Hosp Infect 1995; 30: 313-21.
28. Takala A, Eskola J, Leinonen M, Käyhty H, Nissinen A, Pekkanen E, Mäkelä H. Reduction of oropharyngeal carriage of Haemophilus influenzae type b (Hib) in children immunized with an Hib conjugate vaccine. J Infect Dis 1991; 164: 982-6.
29. Barbour ML, Mayon-White RT, Coles C, Crook DW, Moxon ER. The impact of conjugate vaccine on carriage of Haemophilus influenzae type b. J Infect Dis 1995; 171: 93-8.
30. Johanesson M, Fagerberg B. A health economic comparison of diet and drug treatment in obese men with mild hypertension. J Hypertens 1992; 10: 1063-70.
31. Luce BR, Elixhuser A. Standards for socioeconomic evaluation of health care products and services. Heidelberg: Springer-Verlag, 1990.
32. Persson U. Three economic approaches to valuing benefits of traffic safety measures. Licentiate dissertation in Economics, Lund University, 1992.
33. Persson U, Vegelius C. Revision of accident cost of the National Road Administration - an adjustment to 1997 prices [in Swedish]. University of Lund: Department of Traffic Planning and Engineering, 1995.
34. Kurikka S, Kähty H, Saarinen L, Rönnberg P-R, Eskola J, Mäkelä H. Immunologic priming by one dose of Haemophilus influenzae type b conjugate vaccine in infancy. J Infect Dis 1995; 172; 1268-72.
35. Trollfors B. Cost-benefit analysis of general vaccination against Haemophilus influenzae type b in Sweden. Scand J Infect Dis 1994; 26: 611-4.
36. Hay JW, Daum RS. Cost-benefit analysis of Haemophilus influenzae type b prevention: conjugate vaccination at eighteen months of age. Pediatr Infect Dis J 1990; 9: 246-52.
37. Ginsberg M, Kassis I, Dagan R. Cost benefit analysis of Haemophilus influenzae type b vaccination programme in Israel. J Epidemiol Community Health 1993; 47: 485-90.
38. McIntyre P, Hall J, Leeder S. An economic analysis of alternatives for childhood immunisation against Haemophilus influenzae type b disease. Aust J Public Health 1994; 18: 294-399.
39. Hussey G, Lasser M, Reekie W. The costs and benefits of a vaccination programme for Haemophilus influenzae type b disease. S Afr Med J 1995; 85: 20-5.
40. Taylor H, Michaels R, Mazur P, Bauer R, Liden C. Intellectual, neuropsychological. and achievement outcomes in children six to eight years after recovery from Haemophilus influenzae meningitis. Pediatrics 1984; 74: 198-205.